Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASN002 in Advanced Cancer
NCT02440685Phase 2Terminated
- Sponsor
- Asana BioSciences, LLC
- Start
- May 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gusacitinib in diffuse large B-cell lymphoma (DLBCL), Follicular lymphoma (FL), Mantle cell lymphoma (MCL), peripheral T-cell lymphoma (PTCL), myelofibrosis (MF), sponsored by Asana BioSciences, LLC. Started May 2015; status: terminated.
02
Drugs
gusacitinib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)Follicular lymphoma (FL)Mantle cell lymphoma (MCL)peripheral T-cell lymphoma (PTCL)myelofibrosis (MF)
Beyond the preview
Go deeper on NCT02440685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440685.